571 related articles for article (PubMed ID: 16584978)
1. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.
Maraldi NM; Lattanzi G; Capanni C; Columbaro M; Merlini L; Mattioli E; Sabatelli P; Squarzoni S; Manzoli FA
Eur J Histochem; 2006; 50(1):1-8. PubMed ID: 16584978
[TBL] [Abstract][Full Text] [Related]
2. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
[TBL] [Abstract][Full Text] [Related]
3. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
[TBL] [Abstract][Full Text] [Related]
4. Lamin A/C assembly defects in Emery-Dreifuss muscular dystrophy can be regulated by culture medium composition.
Holt I; Nguyen TM; Wehnert M; Morris GE
Neuromuscul Disord; 2006 Jun; 16(6):368-73. PubMed ID: 16697197
[TBL] [Abstract][Full Text] [Related]
5. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
[TBL] [Abstract][Full Text] [Related]
6. How does a g993t mutation in the emerin gene cause Emery-Dreifuss muscular dystrophy?
Holt I; Clements L; Manilal S; Morris GE
Biochem Biophys Res Commun; 2001 Oct; 287(5):1129-33. PubMed ID: 11587540
[TBL] [Abstract][Full Text] [Related]
7. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.
Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G
J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology.
Maraldi NM; Lattanzi G; Sabatelli P; Ognibene A; Columbaro M; Capanni C; Rutigliano C; Mattioli E; Squarzoni S
Eur J Histochem; 2003; 47(1):3-16. PubMed ID: 12685553
[TBL] [Abstract][Full Text] [Related]
9. Nuclear envelope proteins and neuromuscular diseases.
Ostlund C; Worman HJ
Muscle Nerve; 2003 Apr; 27(4):393-406. PubMed ID: 12661041
[TBL] [Abstract][Full Text] [Related]
10. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
Holt I; Clements L; Manilal S; Brown SC; Morris GE
Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
[TBL] [Abstract][Full Text] [Related]
11. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.
Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA
Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190
[TBL] [Abstract][Full Text] [Related]
12. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.
Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM
Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684
[TBL] [Abstract][Full Text] [Related]
13. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.
Kandert S; Lüke Y; Kleinhenz T; Neumann S; Lu W; Jaeger VM; Munck M; Wehnert M; Müller CR; Zhou Z; Noegel AA; Dabauvalle MC; Karakesisoglou I
Hum Mol Genet; 2007 Dec; 16(23):2944-59. PubMed ID: 17881656
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation.
Reichart B; Klafke R; Dreger C; Krüger E; Motsch I; Ewald A; Schäfer J; Reichmann H; Müller CR; Dabauvalle MC
BMC Cell Biol; 2004 Mar; 5():12. PubMed ID: 15053843
[TBL] [Abstract][Full Text] [Related]
15. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.
Melcon G; Kozlov S; Cutler DA; Sullivan T; Hernandez L; Zhao P; Mitchell S; Nader G; Bakay M; Rottman JN; Hoffman EP; Stewart CL
Hum Mol Genet; 2006 Feb; 15(4):637-51. PubMed ID: 16403804
[TBL] [Abstract][Full Text] [Related]
16. The laminopathies: a clinical review.
Rankin J; Ellard S
Clin Genet; 2006 Oct; 70(4):261-74. PubMed ID: 16965317
[TBL] [Abstract][Full Text] [Related]
17. Pre-Lamin A processing is linked to heterochromatin organization.
Lattanzi G; Columbaro M; Mattioli E; Cenni V; Camozzi D; Wehnert M; Santi S; Riccio M; Del Coco R; Maraldi NM; Squarzoni S; Foisner R; Capanni C
J Cell Biochem; 2007 Dec; 102(5):1149-59. PubMed ID: 17654502
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype.
Fairley EA; Riddell A; Ellis JA; Kendrick-Jones J
J Cell Sci; 2002 Jan; 115(Pt 2):341-54. PubMed ID: 11839786
[TBL] [Abstract][Full Text] [Related]
19. Laminopathies and lamin-associated signaling pathways.
Maraldi NM; Capanni C; Cenni V; Fini M; Lattanzi G
J Cell Biochem; 2011 Apr; 112(4):979-92. PubMed ID: 21400569
[TBL] [Abstract][Full Text] [Related]
20. Emerin and the nuclear lamina in muscle and cardiac disease.
Holaska JM
Circ Res; 2008 Jul; 103(1):16-23. PubMed ID: 18596264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
